The acquisition will be funded through financing of up to $670 million to be raised by IKS Inc. from lenders including Citibank NA and its affiliates, Deutsche Bank AG Singapore Branch, and JPMorgan Chase Bank, NA, Hong Kong Branch, under a proposed facilities agreement.
Under the terms of the agreement, TruBridge shareholders will receive $26.25 in cash for each share of common stock.
As per the exchange filing, the boards of both IKS Inc. and the parent company approved the proposed acquisition and the execution of the merger agreement on April 23, 2026.
Also Read: IEX Q4 Results | Net profit rises 11% on high revenue growth; ₹2 dividend declared
“I am excited for TruBridge and IKS Health to combine forces and expand the focus on strengthening rural and community healthcare,” said Chris Fowler, President and CEO of TruBridge.
He added, “IKS Health shares our passion to improve provider experiences and financial results, ultimately leading to healthier lives and positive patient outcomes. It’s rewarding to know that our employees will have more ways and opportunities to deliver exceptional value to our customers and their patients.”
The firm claimed that proposed strategic acquisition underscores a
commitment to broaden access to high-quality care and support the clinicians and hospitals that serve communities across the United States.
Upon completion, TruBridge Inc. is expected to become a material indirect subsidiary of the company.
Also Read: Bank of Baroda extends MD & CEO Debadatta Chand’s tenure by 3 years
Ahead of the announcement shares of Inventurus Knowledge Solutions Ltd closed at ₹1,435.40 on the NSE on April 23, gaining ₹8.50 or 0.60% for the day.
